We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Imaging Tool Increases Safety of Brain Surgery

By HospiMedica International staff writers
Posted on 25 Oct 2015
A new stimulated Raman scattering (SRS) microscopic technology may help surgeons differentiate between tumor and normal brain tissue in real-time.

Under development at the University of Michigan Health System (U-M; Ann Arbor, MI, USA), New York University (NYU; NY, USA), and other institutions, the SRS microscopy technique is used to produce different signals for proteins and lipids, which can then be assigned a color—blue and green, respectively—to differentiate between brain cortex, tumor tissue, and white matter. More...
To make the approach amenable to routine use in neuropathology, the researchers created an objective classifier that integrates image characteristics (such as protein/lipid ratio, axonal density, and degree of cellularity), into one output that can alert pathologists to tumor infiltration.

The classifier was built using more than 1,400 images from patients with glioblastoma and epilepsy, and can distinguish between tumor-infiltrated and non-tumor regions with over 99% accuracy, regardless of tumor grade or histologic subtype. A subsequent study of biopsies taken from adult and pediatric patients with glioblastoma revealed not only distinctive features with SRS microscopy, but also the presence of infiltrating cells in tissues that appeared otherwise normal when examined with traditional staining techniques. The study was published on October 14, 2015, in Science Translational Medicine.

“SRS imaging technology could be used to complement existing neurosurgical workflows, allowing for rapid and objective characterization of brain tissues and, in turn, clinical decision-making,” concluded lead author neurosurgeon Daniel Orringer, MD, of U-M, and colleagues. “It allows the surgical decision-making process to become data driven instead of relying on the surgeon's best guess. We're able to visualize tumor that otherwise would be invisible to the surgeon in the operating room.”

“This technology has the potential to resolve a long-standing issue in cancer surgery, which is the need for faster and more effective methods to assess whether a tumor has been fully removed,” added Richard Conroy, PhD, of the US National Institutes of Health (NIH; Bethesda, MD, USA), which provided funding for the development of the technology. “The ability to determine tumor margins without having to send samples to a pathologist could increase patient safety and improve outcomes by shortening the length of surgeries and reducing the number of cases where cancer cells are left behind.”

Related Links:

University of Michigan Health System
New York University
US National Institutes of Health



Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.